Every material Form 8-K Astera Labs filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Astera Labs entered a lease on December 16, 2024, for about 154,231 square feet of office space in San Jose, California, to become its new corporate headquarters after construction and expiry of its current lease, estimated in the second quarter of 2025. The filing describes an initial monthly base rent of $385,577.50 with annual increases of about 3%, and a construction allowance of $8,482,705, which can rise to $11,567,325.
Lease covers about 154,231 square feet across three San Jose buildings, with an initial term of 90 months from the Commencement Date.
Initial monthly base rent is $385,577.50, scheduled to rise about 3% per year.
Construction allowance is $8,482,705, with a right to increase it to $11,567,325.
Rent begins on the Rent Commencement Date; the term starts no earlier than April 1, 2025.
Astera Labs reported record third-quarter fiscal 2024 revenue of $113.1 million, up 47% from the prior quarter and up 206% from a year earlier, in an 8-K furnished November 4, 2024. The company posted a GAAP net loss of $7.6 million, or $0.05 per share, and non-GAAP diluted earnings of $0.23 per share, and it gave fourth-quarter revenue guidance of $126 million to $130 million.
Q3 revenue of $113.1 million, up from $76.9 million in Q2 2024 and $36.9 million in Q3 2023
GAAP operating loss narrowed to $8.9 million from $24.3 million in the prior quarter; GAAP net loss was $7.6 million
Non-GAAP diluted EPS of $0.23, compared with $0.13 in Q2 2024
Q4 2024 outlook: revenue of $126 million to $130 million and GAAP gross margin of approximately 75%
Astera Labs reported second-quarter 2024 revenue of $76.9 million, up 18% from the first quarter and 619% from a year earlier. GAAP net loss narrowed to $7.5 million, or $0.05 per share, from $93.0 million in the first quarter, which included IPO-related stock-based compensation. The company expects third-quarter revenue of $95 million to $100 million, and IPO lock-up restrictions on officers, directors and major holders are expected to end at the open of trading on August 8, 2024.
Q2 revenue of $76.9 million, up 18% sequentially and 619% year over year
GAAP net loss of $7.5 million, or $0.05 per share, versus a $93.0 million net loss in Q1 2024
Non-GAAP net income of $22.2 million, or $0.13 per diluted share
Q3 2024 revenue outlook of $95 million to $100 million; lock-up restrictions expected to end August 8, 2024
Astera Labs increased its board from six to seven directors and appointed Bethany Mayer, a former Ixia CEO, as an independent Class I director effective June 23, 2024. Her Audit Committee seat, replacing Stefan Dyckerhoff, takes effect July 25, 2024. The filing reports no financial results, and the appointment is a governance change that adds a director with networking and cybersecurity board experience.
Board expanded from six to seven directors; Mayer appointed effective June 23, 2024
Mayer joins Audit Committee effective July 25, 2024, replacing Stefan Dyckerhoff
Director pay includes a $60,000 prorated annual Board retainer and a $12,500 prorated Audit Committee retainer
One-time RSU award with a fair market value of $330,000, vesting in equal annual installments over three years
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Astera Labs filing is on SEC EDGAR ↗. 8-K briefs of other companies →